FMR LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 480,507 0.400% |
-4,755,014 (-90.82%) |
Filing |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 5,235,521 14.999% |
1,392,134 (+36.22%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,843,387 11.173% |
-84,013 (-2.14%) |
Filing |
| 2023-02-10 09:08 am Purchase |
2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,927,400 11.571% |
975,186 (+33.03%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 2,952,214 8.698% |
-230,487 (-7.24%) |
Filing |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,182,701 10.762% |
933,868 (+41.53%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 2,248,833 7.611% |
2,248,833 (New Position) |
Filing |